{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:47:46Z","timestamp":1782744466445,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,29]]},"DOI":"10.7759\/cureus.111730","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:28:41Z","timestamp":1782743321000},"source":"Crossref","is-referenced-by-count":0,"title":["Decoding Neuropsychiatric Lupus: A Systematic Review of Anti-N-Methyl-D-Aspartate and Anti-ribosomal P Antibodies"],"prefix":"10.7759","author":[{"given":"Raghavee","family":"Neupane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mollie","family":"Goudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pujita","family":"Julakanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Aftab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabiha T","family":"Atiquzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond L","family":"Ownby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M","family":"Kesselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus: a review","volume":"331","author":"Siegel CH","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024, 331:1480-91. 10.1001\/jama.2024.2315","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/art.41632","article-title":"Prevalence of systemic lupus erythematosus in the United States: estimates from a meta-analysis of the Centers for Disease Control and Prevention national lupus registries","volume":"73","author":"Izmirly PM","year":"2021","unstructured":"Izmirly PM, Parton H, Wang L, et al.. Prevalence of systemic lupus erythematosus in the United States: estimates from a meta-analysis of the Centers for Disease Control and Prevention national lupus registries. Arthritis Rheumatol. 2021, 73:991-6. 10.1002\/art.41632","journal-title":"Arthritis Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac610","article-title":"The global epidemiology of SLE: narrowing the knowledge gaps","volume":"62","author":"Barber MR","year":"2023","unstructured":"Barber MR, Falasinnu T, Ramsey-Goldman R, Clarke AE. The global epidemiology of SLE: narrowing the knowledge gaps. Rheumatology (Oxford). 2023, 62:i4-9. 10.1093\/rheumatology\/keac610","journal-title":"Rheumatology (Oxford)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.106351","article-title":"Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus","volume":"69","author":"Hanly JG","year":"2010","unstructured":"Hanly JG, Urowitz MB, Su L, et al.. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis. 2010, 69:529-35. 10.1136\/ard.2008.106351","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055843","article-title":"Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients","volume":"8","author":"Kampylafka EI","year":"2013","unstructured":"Kampylafka EI, Alexopoulos H, Kosmidis ML, et al.. Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. PLoS One. 2013, 8:e55843. 10.1371\/journal.pone.0055843","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318772021","article-title":"Prevalence, risk factors, and impact on mortality of neuropsychiatric lupus: a prospective, single-center study","volume":"27","author":"Ahn GY","year":"2018","unstructured":"Ahn GY, Kim D, Won S, et al.. Prevalence, risk factors, and impact on mortality of neuropsychiatric lupus: a prospective, single-center study. Lupus. 2018, 27:1338-47. 10.1177\/0961203318772021","journal-title":"Lupus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317747720","article-title":"Neuropsychiatric manifestations are not uncommon in Indian lupus patients and negatively affect quality of life","volume":"27","author":"Muhammed H","year":"2018","unstructured":"Muhammed H, Goyal M, Lal V, Singh S, Dhir V. Neuropsychiatric manifestations are not uncommon in Indian lupus patients and negatively affect quality of life. Lupus. 2018, 27:688-93. 10.1177\/0961203317747720","journal-title":"Lupus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz N","year":"2019","unstructured":"Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol. 2019, 15:137-52. 10.1038\/s41584-018-0156-8","journal-title":"Nat Rev Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/injr.injr_37_20","article-title":"The clinical and immunological profiles of systemic lupus erythematosus patients from Assam, north-east India","volume":"15","author":"Talukdar D","year":"2020","unstructured":"Talukdar D, Gogoi AP, Doley D, et al.. The clinical and immunological profiles of systemic lupus erythematosus patients from Assam, north-east India. Indian J Rheumatol. 2020, 15:181-6. 10.4103\/injr.injr_37_20","journal-title":"Indian J Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01667","article-title":"Anti-double stranded DNA antibodies: origin, pathogenicity, and targeted therapies","volume":"10","author":"Wang X","year":"2019","unstructured":"Wang X, Xia Y. Anti-double stranded DNA antibodies: origin, pathogenicity, and targeted therapies. Front Immunol. 2019, 10:1667. 10.3389\/fimmu.2019.01667","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08898-7","article-title":"The therapeutic strategies for SLE by targeting anti-dsDNA antibodies","volume":"63","author":"Wang Y","year":"2022","unstructured":"Wang Y, Xiao S, Xia Y, Wang H. The therapeutic strategies for SLE by targeting anti-dsDNA antibodies. Clin Rev Allergy Immunol. 2022, 63:152-65. 10.1007\/s12016-021-08898-7","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s1297-319x(02)00366-4","article-title":"Autoantibodies to ribosomal P proteins in systemic lupus erythematosus","volume":"69","author":"Yalaoui S","year":"2002","unstructured":"Yalaoui S, Gorgi Y, Hajri R, Goucha R, Chaabouni L, Kooli C, Ayed K. Autoantibodies to ribosomal P proteins in systemic lupus erythematosus. Joint Bone Spine. 2002, 69:173-6. 10.1016\/s1297-319x(02)00366-4","journal-title":"Joint Bone Spine"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08865-2","article-title":"Autoantibodies in neuropsychiatric systemic lupus erythematosus (NPSLE): can they be used as biomarkers for the differential diagnosis of this disease?","volume":"63","author":"Manca E","year":"2022","unstructured":"Manca E. Autoantibodies in neuropsychiatric systemic lupus erythematosus (NPSLE): can they be used as biomarkers for the differential diagnosis of this disease?. Clin Rev Allergy Immunol. 2022, 63:194-209. 10.1007\/s12016-021-08865-2","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/76711","article-title":"Cognitive impairment, event-related potentials and immunological status in patients with systemic lupus erythematosus","volume":"28","author":"Szmyrka M","year":"2019","unstructured":"Szmyrka M, Pokryszko-Dragan A, S\u0142otwi\u0144ski K, Gruszka E, Korman L, Podemski R, Wiland P. Cognitive impairment, event-related potentials and immunological status in patients with systemic lupus erythematosus. Adv Clin Exp Med. 2019, 28:185-92. 10.17219\/acem\/76711","journal-title":"Adv Clin Exp Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14111186","article-title":"The challenge of neuropsychiatric systemic lupus erythematosus: from symptoms to therapeutic strategies","volume":"14","author":"Patel V","year":"2024","unstructured":"Patel V. The challenge of neuropsychiatric systemic lupus erythematosus: from symptoms to therapeutic strategies. Diagnostics (Basel). 2024, 14:1186. 10.3390\/diagnostics14111186","journal-title":"Diagnostics (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani M","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016, 5:210. 10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000061","article-title":"Diagnostic test accuracy: methods for systematic review and meta-analysis","volume":"13","author":"Campbell JM","year":"2015","unstructured":"Campbell JM, Klugar M, Ding S, et al.. Diagnostic test accuracy: methods for systematic review and meta-analysis. Int J Evid Based Healthc. 2015, 13:154-62. 10.1097\/XEB.0000000000000061","journal-title":"Int J Evid Based Healthc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5047898","article-title":"Autoantibodies to NR2A peptide of the glutamate\/NMDA receptor in patients with seizure disorders in neuropsychiatric systemic lupus erythematosus","volume":"2017","author":"Yang Y","year":"2017","unstructured":"Yang Y, Yuan C, Shen SQ, Wang XE, Mei QH, Jiang WQ, Huang Q. Autoantibodies to NR2A peptide of the glutamate\/NMDA receptor in patients with seizure disorders in neuropsychiatric systemic lupus erythematosus. Mediators Inflamm. 2017, 2017:5047898. 10.1155\/2017\/5047898","journal-title":"Mediators Inflamm"},{"key":"ref20","article-title":"Anti-N-methyl-D-aspartate receptor antibodies are associated with fibromyalgia in patients with systemic lupus erythematosus: a case-control study","volume":"35","author":"Park DJ","year":"2017","unstructured":"Park DJ, Takahashi Y, Kang JH, et al.. Anti-N-methyl-D-aspartate receptor antibodies are associated with fibromyalgia in patients with systemic lupus erythematosus: a case-control study. Clin Exp Rheumatol. 2017, 35:54-60.","journal-title":"Clin Exp Rheumatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2019-000359","article-title":"Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosus","volume":"6","author":"Hirohata S","year":"2019","unstructured":"Hirohata S, Tanaka K. Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosus. Lupus Sci Med. 2019, 6:e000359. 10.1136\/lupus-2019-000359","journal-title":"Lupus Sci Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13392","article-title":"Clinical significance of anti-DNA\/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus","volume":"22","author":"Fujieda Y","year":"2019","unstructured":"Fujieda Y, Mader S, Jeganathan V, et al.. Clinical significance of anti-DNA\/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus. Int J Rheum Dis. 2019, 22:443-8. 10.1111\/1756-185X.13392","journal-title":"Int J Rheum Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215098","article-title":"Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies","volume":"78","author":"Schwarting A","year":"2019","unstructured":"Schwarting A, M\u00f6ckel T, L\u00fctgendorf F, et al.. Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies. Ann Rheum Dis. 2019, 78:1226-34. 10.1136\/annrheumdis-2019-215098","journal-title":"Ann Rheum Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043560","article-title":"NMDA receptors in health and diseases: new roles and signaling pathways - anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies as potential biomarkers of fatigue in patients with rheumatic diseases","volume":"24","author":"Marinoska T","year":"2023","unstructured":"Marinoska T, M\u00f6ckel T, Triantafyllias K, Boegel S, Dreher M, Luessi F, Schwarting A. NMDA receptors in health and diseases: new roles and signaling pathways - anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies as potential biomarkers of fatigue in patients with rheumatic diseases. Int J Mol Sci. 2023, 24:3560. 10.3390\/ijms24043560","journal-title":"Int J Mol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3339-1","article-title":"Anti-NR2 antibodies, blood-brain barrier, and cognitive dysfunction","volume":"35","author":"Gulati G","year":"2016","unstructured":"Gulati G, Iffland PH 2nd, Janigro D, Zhang B, Luggen ME. Anti-NR2 antibodies, blood-brain barrier, and cognitive dysfunction. Clin Rheumatol. 2016, 35:2989-97. 10.1007\/s10067-016-3339-1","journal-title":"Clin Rheumatol"},{"key":"ref26","article-title":"Relationship between disease activity, levels of IFN-a, IL-4, IL-6, and anti-NMDA to cognitive dysfunction (MoCA-INA score) in systemic lupus erythematosus (SLE) patients with cognitive dysfunction","volume":"55","author":"Suntoko B","year":"2023","unstructured":"Suntoko B, Hadisaputro S, Kalim H, Hadi S, Saputra WA. Relationship between disease activity, levels of IFN-a, IL-4, IL-6, and anti-NMDA to cognitive dysfunction (MoCA-INA score) in systemic lupus erythematosus (SLE) patients with cognitive dysfunction. Acta Med Indones. 2023, 55:307-14.","journal-title":"Acta Med Indones"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04707-x","article-title":"Predictors of damage accrual in systemic lupus erythematosus: a longitudinal observational study with focus on neuropsychological factors and anti-neuronal antibodies","volume":"38","author":"Mimica M","year":"2019","unstructured":"Mimica M, Barra I, Orme\u00f1o R, et al.. Predictors of damage accrual in systemic lupus erythematosus: a longitudinal observational study with focus on neuropsychological factors and anti-neuronal antibodies. Clin Rheumatol. 2019, 38:3129-37. 10.1007\/s10067-019-04707-x","journal-title":"Clin Rheumatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S387650","article-title":"Anti-ribosomal-P antibody association with neuropsychiatric lupus in Sudanese patients attending rheumatology clinic in Omdurman Military Hospital","volume":"14","author":"Taha ZI","year":"2022","unstructured":"Taha ZI, Awad Ibrahim IA, Hamza SB, et al.. Anti-ribosomal-P antibody association with neuropsychiatric lupus in Sudanese patients attending rheumatology clinic in Omdurman Military Hospital. Open Access Rheumatol. 2022, 14:281-9. 10.2147\/OARRR.S387650","journal-title":"Open Access Rheumatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1349042","article-title":"Clinical features and outcomes of neuropsychiatric systemic lupus erythematosus in China","volume":"2021","author":"Zhang S","year":"2021","unstructured":"Zhang S, Li M, Zhang L, et al.. Clinical features and outcomes of neuropsychiatric systemic lupus erythematosus in China. J Immunol Res. 2021, 2021:1349042. 10.1155\/2021\/1349042","journal-title":"J Immunol Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/biom13030567","article-title":"Association between inflammation and thrombotic pathway link with pathogenesis of depression and anxiety in SLE patients","volume":"13","author":"Duca L","year":"2023","unstructured":"Duca L, Roman N, Teodorescu A, Ifteni P. Association between inflammation and thrombotic pathway link with pathogenesis of depression and anxiety in SLE patients. Biomolecules. 2023, 13:567. 10.3390\/biom13030567","journal-title":"Biomolecules"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-3114-z","article-title":"Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from western India","volume":"35","author":"Pradhan V","year":"2015","unstructured":"Pradhan V, Patwardhan M, Rajadhyaksha A, Dhawale N, Ghosh K. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from western India. Rheumatol Int. 2015, 35:541-5. 10.1007\/s00296-014-3114-z","journal-title":"Rheumatol Int"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2023-001005","article-title":"Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study","volume":"10","author":"Chessa E","year":"2023","unstructured":"Chessa E, Piga M, Perra A, et al.. Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study. Lupus Sci Med. 2023, 10:e001005. 10.1136\/lupus-2023-001005","journal-title":"Lupus Sci Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1177\/09612033251324467","article-title":"Clinical features of anti-ribosomal P protein antibodies in systemic lupus erythematosus: a single-center retrospective study in China","volume":"34","author":"Ma J","year":"2025","unstructured":"Ma J, Zhang L, Yan M, Lu C, Xue L. Clinical features of anti-ribosomal P protein antibodies in systemic lupus erythematosus: a single-center retrospective study in China. Lupus. 2025, 34:358-64. 10.1177\/09612033251324467","journal-title":"Lupus"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2018.1508801","article-title":"Anti-ribosomal P protein antibodies influence mortality of patients with diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematous involving a severe form of the disease","volume":"29","author":"Arinuma Y","year":"2019","unstructured":"Arinuma Y, Kikuchi H, Hirohata S. Anti-ribosomal P protein antibodies influence mortality of patients with diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematous involving a severe form of the disease. Mod Rheumatol. 2019, 29:612-8. 10.1080\/14397595.2018.1508801","journal-title":"Mod Rheumatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/jalm\/jfab045","article-title":"Association of antiribosomal P antibody with neurological and systemic manifestations in patients with systemic lupus erythematosus in southwestern Colombia","volume":"7","author":"Mar\u00edn JD","year":"2022","unstructured":"Mar\u00edn JD, Vargas S, Ruiz-Ordo\u00f1ez I, et al.. Association of antiribosomal P antibody with neurological and systemic manifestations in patients with systemic lupus erythematosus in southwestern Colombia. J Appl Lab Med. 2022, 7:3-11. 10.1093\/jalm\/jfab045","journal-title":"J Appl Lab Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11217","article-title":"Role of serum IL-6 in neuropsychiatric systemic lupus erythematosus","volume":"3","author":"Hirohata S","year":"2021","unstructured":"Hirohata S, Kikuchi H. Role of serum IL-6 in neuropsychiatric systemic lupus erythematosus. ACR Open Rheumatol. 2021, 3:42-9. 10.1002\/acr2.11217","journal-title":"ACR Open Rheumatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2025-001550","article-title":"Anti-ribosomal-P protein antibodies and systemic lupus erythematosus (SLE): in a cross-sectional study of Danish adult patients with SLE, no significant association is found between anti-ribosomal-P and neuropsychiatric SLE","volume":"12","author":"Kamstrup SL","year":"2025","unstructured":"Kamstrup SL, Schmidt NS, Langkilde HZ, Nilsson AC, Voss A. Anti-ribosomal-P protein antibodies and systemic lupus erythematosus (SLE): in a cross-sectional study of Danish adult patients with SLE, no significant association is found between anti-ribosomal-P and neuropsychiatric SLE. Lupus Sci Med. 2025, 12:e001550. 10.1136\/lupus-2025-001550","journal-title":"Lupus Sci Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2015.1083163","article-title":"Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus","volume":"26","author":"Ogawa E","year":"2016","unstructured":"Ogawa E, Nagai T, Sakuma Y, Arinuma Y, Hirohata S. Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus. Mod Rheumatol. 2016, 26:377-83. 10.3109\/14397595.2015.1083163","journal-title":"Mod Rheumatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320954918","article-title":"Association of anti-NR2 and U1RNP antibodies with neurotoxic inflammatory mediators in cerebrospinal fluid from patients with neuropsychiatric systemic lupus erythematosus","volume":"29","author":"Kondo-Ishikawa S","year":"2020","unstructured":"Kondo-Ishikawa S, Fujii T, Ishigooka N, et al.. Association of anti-NR2 and U1RNP antibodies with neurotoxic inflammatory mediators in cerebrospinal fluid from patients with neuropsychiatric systemic lupus erythematosus. Lupus. 2020, 29:1673-82. 10.1177\/0961203320954918","journal-title":"Lupus"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2024.12.001","article-title":"Exploring immune-mediated brain function abnormalities in systemic lupus erythematosus: neuroimaging evidence of the impact of anti-ribosomal P protein antibodies","volume":"32","author":"Liang S","year":"2025","unstructured":"Liang S, Maitiyaer M, Tan Q, et al.. Exploring immune-mediated brain function abnormalities in systemic lupus erythematosus: neuroimaging evidence of the impact of anti-ribosomal P protein antibodies. Acad Radiol. 2025, 32:2889-99. 10.1016\/j.acra.2024.12.001","journal-title":"Acad Radiol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316629556","article-title":"IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus","volume":"25","author":"Yoshio T","year":"2016","unstructured":"Yoshio T, Okamoto H, Kurasawa K, Dei Y, Hirohata S, Minota S. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus. Lupus. 2016, 25:997-1003. 10.1177\/0961203316629556","journal-title":"Lupus"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320908940","article-title":"Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India","volume":"29","author":"Seth G","year":"2020","unstructured":"Seth G, Sundaresh A, Mariaselvam CM, et al.. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India. Lupus. 2020, 29:413-20. 10.1177\/0961203320908940","journal-title":"Lupus"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10290-y","article-title":"Neurofilament light is a biomarker of brain involvement in lupus and primary Sj\u00f6gren's syndrome","volume":"268","author":"Tjensvoll AB","year":"2021","unstructured":"Tjensvoll AB, Lauvsnes MB, Zetterberg H, et al.. Neurofilament light is a biomarker of brain involvement in lupus and primary Sj\u00f6gren's syndrome. J Neurol. 2021, 268:1385-94. 10.1007\/s00415-020-10290-y","journal-title":"J Neurol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320958061","article-title":"Prevalence, involved domains, and predictor of cognitive dysfunction in systemic lupus erythematosus","volume":"29","author":"Yue R","year":"2020","unstructured":"Yue R, Gurung I, Long XX, Xian JY, Peng XB. Prevalence, involved domains, and predictor of cognitive dysfunction in systemic lupus erythematosus. Lupus. 2020, 29:1743-51. 10.1177\/0961203320958061","journal-title":"Lupus"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab160","article-title":"Psychosis in systemic lupus erythematosus (SLE): 40-year experience of a specialist centre","volume":"60","author":"Abrol E","year":"2021","unstructured":"Abrol E, Coutinho E, Chou M, et al.. Psychosis in systemic lupus erythematosus (SLE): 40-year experience of a specialist centre. Rheumatology (Oxford). 2021, 60:5620-9. 10.1093\/rheumatology\/keab160","journal-title":"Rheumatology (Oxford)"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317742711","article-title":"Suicidal ideation in systemic lupus erythematosus: NR2A gene polymorphism, clinical and psychosocial factors","volume":"27","author":"Buji RI","year":"2018","unstructured":"Buji RI, Abdul Murad NA, Chan LF, et al.. Suicidal ideation in systemic lupus erythematosus: NR2A gene polymorphism, clinical and psychosocial factors. Lupus. 2018, 27:744-52. 10.1177\/0961203317742711","journal-title":"Lupus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/495124-decoding-neuropsychiatric-lupus-a-systematic-review-of-anti-n-methyl-d-aspartate-and-anti-ribosomal-p-antibodies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:28:42Z","timestamp":1782743322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/495124-decoding-neuropsychiatric-lupus-a-systematic-review-of-anti-n-methyl-d-aspartate-and-anti-ribosomal-p-antibodies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.111730","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}